本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Solid Biosciences

7.00
+0.32004.79%
盘后6.98-0.0201-0.29%19:55 EDT
成交量:151.58万
成交额:1,026.34万
市值:5.43亿
市盈率:-2.40
高:7.00
开:6.70
低:6.47
收:6.68
数据加载中...
2024/01/23

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/12

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/12

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/10

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/09

重要事件披露

Form 8-K - Current report
2023/06/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/23

重要事件披露

Form 8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/20

重要事件披露

8-K - Current report
2023/03/13

重要事件披露

8-K - Current report
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals